Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/18/2001 | CA2405870A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia |
10/18/2001 | CA2405800A1 Novel secreted protein |
10/18/2001 | CA2405769A1 A method of distinguishing between living and dead cells using viability probes |
10/18/2001 | CA2405750A1 Protein kinase stress-related proteins and methods of use in plants |
10/18/2001 | CA2405730A1 Serine-threonine kinase |
10/18/2001 | CA2405725A1 Identification of a novel dual specificity phosphataes |
10/18/2001 | CA2405708A1 Gtp binding stress-related proteins and methods of use in plants |
10/18/2001 | CA2405687A1 Process for allele discrimation utilizing primer extension |
10/18/2001 | CA2405445A1 Fertility associated antigen and methods of use thereof |
10/18/2001 | CA2405311A1 Multiprotein-complexes comprising a nmda receptor and uses thereof |
10/18/2001 | CA2405291A1 Methods of using growth factors for treating heart disease |
10/18/2001 | CA2405181A1 Human pyruvate dehydrogenese phosphatase |
10/18/2001 | CA2405124A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
10/18/2001 | CA2405104A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
10/18/2001 | CA2405083A1 New bromodomain protein |
10/18/2001 | CA2404988A1 Listeria monocytogenes genome, polypeptides and uses |
10/18/2001 | CA2404971A1 Human protein kinases and protein kinase-like enzymes |
10/18/2001 | CA2404779A1 Human lipid binding protein 1 |
10/18/2001 | CA2404634A1 Human mullerian duct-derived epithelial cells and methods of isolation and uses thereof |
10/18/2001 | CA2404355A1 Methods for screening and identifying host pathogen defense genes |
10/18/2001 | CA2404229A1 Human transporters and ion channels |
10/18/2001 | CA2403946A1 Genes expressed in foam cell differentiation |
10/18/2001 | CA2403941A1 In-situ detection and analysis of methane in coal bed methane formations with spectrometers |
10/18/2001 | CA2403425A1 Multivalent antibodies and uses therefor |
10/18/2001 | CA2403317A1 Mutant bank |
10/18/2001 | CA2403140A1 Novel chromosomal vectors and uses thereof |
10/18/2001 | CA2403003A1 T2r taste receptors and genes encoding same |
10/18/2001 | CA2402410A1 The high bone mass gene of 11q13.3 |
10/18/2001 | CA2402392A1 Non-endogenous, constitutively activated known g protein-coupled receptors |
10/18/2001 | CA2402195A1 Signal sequence trapping |
10/18/2001 | CA2401290A1 Novel g protein-coupled receptor protein and dna thereof |
10/18/2001 | CA2400746A1 Method of producing adenoviral vector stocks |
10/18/2001 | CA2343602A1 Est's and encoded human proteins |
10/17/2001 | EP1146339A2 Methods for judging resistance to the onset of bovine leukemia |
10/17/2001 | EP1146129A2 Method for the identification of oligonucleotide sequences for nucleic acid amplification methods |
10/17/2001 | EP1146127A2 Method for displaying gene experiment data |
10/17/2001 | EP1146125A1 Poxvirus with targeted infection specificity |
10/17/2001 | EP1146124A2 Gustducin materials and methods |
10/17/2001 | EP1146122A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor) |
10/17/2001 | EP1146056A1 Antibodies which activate an erythropoietin receptor |
10/17/2001 | EP1146055A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor) |
10/17/2001 | EP1146054A1 ReL1A BINDING INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF |
10/17/2001 | EP1146053A1 Meg-4 protein |
10/17/2001 | EP1146052A2 Arthropod defensins |
10/17/2001 | EP1146049A2 Process for separating double-stranded/single-stranded nucleic acid structures |
10/17/2001 | EP1145721A2 Human G-protein chemokine receptor HDGNR10 (CCR5 receptor) |
10/17/2001 | EP1145644A2 Glycoprotein having inhibitory activity against helicobacter pylori colonization |
10/17/2001 | EP1145448A2 Radio communications unit |
10/17/2001 | EP1145011A2 Compositions and methods for the diagnosis and treatment of tumor |
10/17/2001 | EP1145010A1 Purification process using magnetic particles |
10/17/2001 | EP1144998A2 Neisseria genomic sequences and methods of their use |
10/17/2001 | EP1144692A1 Method for separating nucleic acids into populations |
10/17/2001 | EP1144690A1 Antisense modulation of cellular inhibitor of apoptosis-2 expression |
10/17/2001 | EP1144689A1 Dna sequencing method which employs various dna polymerases and kit used for the same |
10/17/2001 | EP1144688A1 Dna sequencing method which employs various nucleotide mixtures and kit used for the same |
10/17/2001 | EP1144687A2 Method for the affinity isolation of newly synthesized rna |
10/17/2001 | EP1144686A2 Genetic predisposition to abnormal calcification conditions |
10/17/2001 | EP1144685A2 Method for electrochemically detecting nucleic acid-oligomer hybridisation events |
10/17/2001 | EP1144682A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
10/17/2001 | EP1144681A2 Methods and kits for discovery of rna-binding compounds |
10/17/2001 | EP1144679A2 Capillary array-based sample screening |
10/17/2001 | EP1144678A2 Susceptibility to psoriasis |
10/17/2001 | EP1144676A2 Test kit and method for quantitatively detecting genetically modified dna in foodstuff by means of fluorescence-coupled pcr |
10/17/2001 | EP1144673A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
10/17/2001 | EP1144672A2 Tryptophan synthase as a site of herbicide action |
10/17/2001 | EP1144669A1 Method and apparatus for the automated generation of nucleic acid ligands |
10/17/2001 | EP1144667A2 Retroviral expression vectors on the basis of herv- long terminal repeat sequences |
10/17/2001 | EP1144666A2 Replication deficient baculovirus expression system |
10/17/2001 | EP1144665A1 Methods for transforming plastids |
10/17/2001 | EP1144664A1 Transformation and regeneration of allium plants |
10/17/2001 | EP1144663A1 Method of increasing the water soluble antioxidant content in mechanically harvested peas |
10/17/2001 | EP1144662A1 Methods and means for modification of plant characteristics using the vernalization gene vrn2 |
10/17/2001 | EP1144661A2 Method of genetic modification of a wild type viral sequence |
10/17/2001 | EP1144659A2 Trans-acting factors in yeast |
10/17/2001 | EP1144658A2 Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells |
10/17/2001 | EP1144657A2 Molecular-biological marker for analytical electron microscopy |
10/17/2001 | EP1144656A2 Method for the isolation of ccc plasmid dna |
10/17/2001 | EP1144655A2 Regulated expression using conditional er retention domains |
10/17/2001 | EP1144654A2 Serine protease |
10/17/2001 | EP1144653A2 THERMOSTABLE ENZYME PROMOTING THE FIDELITY OF THERMOSTABLE DNA POLYMERASES- FOR IMPROVEMENT OF NUCLEIC ACID SYNTHESIS AND AMPLIFICATION i IN VITRO /i |
10/17/2001 | EP1144652A1 Manipulating isoprenoid expression |
10/17/2001 | EP1144651A1 Polypeptides derived from jnk3 |
10/17/2001 | EP1144650A2 Goodpasture antigen binding protein |
10/17/2001 | EP1144649A2 Lysophosphatidic acid acetyltransferases |
10/17/2001 | EP1144648A1 Cyclic nucleotide-associated proteins |
10/17/2001 | EP1144647A2 Method of improving the primary energy metabolism of mammalian cell lines |
10/17/2001 | EP1144646A2 Mutant hepatitis b surface antigen and testing |
10/17/2001 | EP1144645A1 Neisseria meningitidis polypeptide basb052 |
10/17/2001 | EP1144644A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
10/17/2001 | EP1144643A1 Neisseria meningitidis antigen |
10/17/2001 | EP1144642A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
10/17/2001 | EP1144641A2 Serotype-specific probes for listeria monocytogenes |
10/17/2001 | EP1144640A2 Nucleic acids and proteins from streptococcus pneumoniae |
10/17/2001 | EP1144639A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
10/17/2001 | EP1144638A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
10/17/2001 | EP1144637A2 Wuschel (wus) gene homologs |
10/17/2001 | EP1144636A2 Human genes and gene expression products |
10/17/2001 | EP1144635A1 Putative genes encoding skeletal muscle voltage-gated calcium channel gamma subunits |
10/17/2001 | EP1144634A2 Novel complex-forming proteins |
10/17/2001 | EP1144633A1 Polypeptide |